Terminated PHASE2 INTERVENTIONAL 2-arm NCT00324558

Adjuvant BEmiparin in Small Cell Lung Carcinoma (ABEL STUDY)

Multicenter, Randomized, Open and Sequential Study to Evaluate the Efficacy and Safety of Bemiparin Administration on the Response to Treatment in Patients Diagnosed With Limited Small Cell Lung Cancer

Sponsor: Clinica Universidad de Navarra, Universidad de Navarra

Conditions Carcinoma, Small Cell

Interventions Bemiparin

Updated 6 times since 2017 Last updated: Jun 7, 2012 Started: Jun 30, 2005 Primary completion: Feb 28, 2010 Completion: Sep 30, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Sponsor stopped due to difficulties to recruit 130 patients required by protocol

Other terminated trials from Clinica Universidad de Navarra, Universidad de Navarra

See all terminations from Clinica Universidad de Navarra, Universidad de Navarra

This PHASE2 trial investigates Carcinoma, Small Cell and is currently terminated or withdrawn. Clinica Universidad de Navarra, Universidad de Navarra leads this study, which shows 6 recorded versions since 2005 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Terminated PHASE2
Sep 2024 — Sep 2025 [monthly]

Terminated PHASE2
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE2
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE2
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE2

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Terminated PHASE2

First recorded

Jun 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Clinica Universidad de Navarra, Universidad de Navarra

Data source: Clinica Universidad de Navarra, Universidad de Navarra

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Alicante, Spain , Barakaldo, Spain , Barcelona, Spain , Córdoba, Spain , Murcia, Spain , Málaga, Spain , Pamplona, Spain , Port de Sagunt, Spain , Puerto Real, Spain , Salamanca, Spain and 4 more locations